Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Journal of Leukemia (Los Angeles, Calif.)|February 28, 2017
Engraftment of Human Primary Acute Myeloid Leukemia Defined by Integrated Genetic Profiling in NOD/SCID/IL2rγnull Mice for Preclinical Ceramide-Based Therapeutic EvaluationBrian M Barth, Nichole R Keasey, Xujung Wang, et al.
Blood|August 2, 2018
Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesisElodie Pronier, Robert L Bowman, Jihae Ahn, et al.
Hematological Oncology|April 24, 2019
Emerging translational science discoveries, clonal approaches, and treatment trends in chronic myeloproliferative neoplasmsTariq I Mughal, Naveen Pemmaraju, Jerald P Radich, et al.
Cancer Discovery|March 5, 2014
Efficacy of intermittent combined RAF and MEK inhibition in a patient with concurrent BRAF- and NRAS-mutant malignanciesOmar Abdel-Wahab, Virginia M Klimek, Alisa A Gaskell, et al.
Blood Advances|February 2, 2018
Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemiaPeter G Maslak, Tao Dao, Yvette Bernal, et al.
Ebiomedicine|May 6, 2018
Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating AgentsMatthieu Duchmann, Fevzi F Yalniz, Alessandro Sanna, et al.
Blood|April 18, 2014
Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesisRaajit Rampal, Fatima Al-Shahrour, Omar Abdel-Wahab, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 12, 2018
Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 StudyVikas Gupta, Heidi E Kosiorek, Adam Mead, et al.
Blood Cancer Journal|April 11, 2026
CMML2AML: machine-learning discovery of co-mutations and specific single mutations predictive of blast transformation in chronic myelomonocytic leukemiaSaubia Fathima, Lior Rokach, Muhammad Yousuf, et al.
Nature|March 15, 2019
Efficacy of MEK inhibition in patients with histiocytic neoplasmsEli L Diamond, Benjamin H Durham, Gary A Ulaner, et al.
Pageof 8